Aethlon Medical (AEMD) EBITDA Margin (2011 - 2023)
Aethlon Medical's (AEMD) quarterly EBITDA Margin came in at 431.51% in Q1 2023, up 2843170.0% YoY from N/an in Q1 2022, and up 98.5% on a QoQ basis from 28863.21% in Q1 2022.
Aethlon Medical (AEMD) EBITDA Margin (2011 - 2023) Analysis & Trends
Aethlon Medical (AEMD) has 13 years of EBITDA Margin data on file, last reported at 431.51% in Q1 2023.
- Quarterly EBITDA Margin rose 2843170.0% year-over-year to 431.51% in Q1 2023, while the trailing twelve-month figure through Mar 2023 was 2072.12% (up 147041.0% YoY) and the FY2023 annual result came in at 2072.05%, up 147048.0% from the prior year.
- EBITDA Margin grew to 431.51% in Q1 2023, from 28863.21% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 211.97% in Q4 2019 to a low of 28863.21% in Q1 2022.
- A 5-year average of 5678.8% and a median of 1590.14% in 2021 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2022 — EBITDA Margin sank 2224803 bps — and 2023, when it surged 2843170 bps.
- Tracing AEMD's EBITDA Margin over 5 years: stood at 211.97% in 2019, then plunged by 85 bps to 391.18% in 2020, then slumped by 3675 bps to 14768.63% in 2021, then sank by 95 bps to 28863.21% in 2022, then jumped by 99 bps to 431.51% in 2023.
- The last three EBITDA Margin figures came in at 431.51% (Q1 2023), 28863.21% (Q1 2022), and 14768.63% (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 19.15% |
| 10 | Aethlon Medical | 1.04 Mn | 1.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -431.51% |
| Mar 31, 2022 | -28,863.21% |
| Dec 31, 2021 | -14,768.63% |
| Sep 30, 2021 | -1,522.21% |
| Jun 30, 2021 | -1,590.14% |
| Mar 31, 2021 | -6,615.18% |
| Dec 31, 2020 | -391.18% |
| Mar 31, 2020 | -863.54% |
| Dec 31, 2019 | -211.97% |
| Jun 30, 2019 | -5,220.63% |
| Mar 31, 2019 | -1,988.65% |
| Jun 30, 2018 | -733.35% |
| Mar 31, 2018 | -1,699.01% |
| Dec 31, 2017 | -1,555.38% |
| Sep 30, 2016 | -574.72% |
| Jun 30, 2016 | -24,415.36% |
| Mar 31, 2016 | -530.81% |
| Dec 31, 2015 | -360.14% |
| Sep 30, 2015 | -596.90% |
| Jun 30, 2015 | -566.20% |